CoChat

Helper-free Production of Laboratory Grade AAV and Purification by Iodixanol Density Gradient Centrifugation

Open access
Crosson, Sean M., Dib, Peter, Smith, J. Kennon, Zolotukhin, Sergei · 2018 · Molecular Therapy - Methods & Clinical Development
Cited by 79

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Adeno-associated virus (AAV) is one of the most promising gene therapy vectors and is widely used as a gene delivery vehicle for basic research. As AAV continues to become the vector of choice, it is increasingly important for new researchers to have access to a simplified production and purification protocol for laboratory grade recombinant AAV. Here we report a detailed protocol for serotype independent production of AAV using a helper-free HEK293 cell system followed by iodixanol gradient purification, a method described earlier. 1 While the core principals of this mammalian AAV production system are unchanged, there have been significant advancements in the production and purification procedure that serve to boost yield, maximize efficiency, and increase the purity of AAV preps. Using this protocol, we are able to constantly obtain high quantities of laboratory grade AAV particles (>5 × 10 12 vg) in a week's time, largely independent of serotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.omtm.2018.05.001

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 11

  1. Zolotukhin, 1999, Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield, Gene Ther., 6, 973, 10.1038/sj.gt.3300938 · DOI · Paper page
  2. Podsakoff, 1994, Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors, J. Virol., 68, 5656, 10.1128/jvi.68.9.5656-5666.1994 · DOI · Paper page
  3. Flotte, 1998, A fluorescence video-endoscopy technique for detection of gene transfer and expression, Gene Ther., 5, 166, 10.1038/sj.gt.3300579 · DOI
  4. Senís, 2014, CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox, Biotechnol. J., 9, 1402, 10.1002/biot.201400046 · DOI · Paper page
  5. Booth, 2004, Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids, Gene Ther., 11, 829, 10.1038/sj.gt.3302226 · DOI
  6. Urabe, 2002, Insect cells as a factory to produce adeno-associated virus type 2 vectors, Hum. Gene Ther., 13, 1935, 10.1089/10430340260355347 · DOI · Paper page
  7. Mietzsch, 2014, OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy, Hum. Gene Ther., 25, 212, 10.1089/hum.2013.184 · DOI · Paper page
  8. Zolotukhin, 2002, Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors, Methods, 28, 158, 10.1016/S1046-2023(02)00220-7 · DOI · Paper page
  9. Zolotukhin, 1996, A “humanized” green fluorescent protein cDNA adapted for high-level expression in mammalian cells, J. Virol., 70, 4646, 10.1128/jvi.70.7.4646-4654.1996 · DOI · Paper page
  10. Hildinger, 2001, Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer, J. Virol., 75, 6199, 10.1128/JVI.75.13.6199-6203.2001 · DOI · Paper page
  11. Grieger, 2016, Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector, Mol. Ther., 24, 287, 10.1038/mt.2015.187 · DOI · Paper page

Cited by

See all 79

Metadata

Authors
Crosson, S. M., Dib, P., Smith, J. K., & Zolotukhin, S.
Venue
Molecular Therapy - Methods & Clinical Development
Publisher
Elsevier BV
Published
2018-09
Volume
10
Pages
1-7
ISSN
2329-0501 (ISSN-L)
OpenAlex
W2800711204
Cited by
79
References
7
FWCI
4.44
Type
journal article
Language
en
Open access
gold
Licence
Funders
National Institute on Deafness and Other Communication Disorders (F31DC015751, R01DC012819)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Helper-free Production of Laboratory Grade AAV and Purification by Iodixanol Density Gradient Centrifugation. https://app.cochat.ai/papers/10.1016/j.omtm.2018.05.001
The paper
Crosson, S. M., Dib, P., Smith, J. K., & Zolotukhin, S. (2018). Helper-free Production of Laboratory Grade AAV and Purification by Iodixanol Density Gradient Centrifugation. Molecular Therapy - Methods & Clinical Development. https://doi.org/10.1016/j.omtm.2018.05.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.